Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Chames

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Medecine Sciences : M/S|December 29, 2009
[The future of antibody fragments, made of a single immunoglobulin domain]Patrick Chames, Daniel Baty
Mabs|January 16, 2010
Bispecific antibodies for cancer therapy: the light at the end of the tunnel?Patrick Chames, Daniel Baty
Current Opinion in Drug Discovery & Development|April 1, 2009
Bispecific antibodies for cancer therapyPatrick Chames, Daniel Baty
Medecine Sciences : M/S|January 7, 2020
[Bispecific antibodies, novel therapeutic candidates harnessing the immune system]Patrick Chames, Thierry Wurch
Methods in Molecular Biology (Clifton, N.J.)|September 10, 2018
Phage Display and Selections on Purified AntigensMagali Colazet, Patrick Chames
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Phage display and selections on purified antigensJulie Matz, Patrick Chames
Antibodies (Basel, Switzerland)|March 12, 2020
Special Issue: NanobodyPatrick Chames, Ulrich Rothbauer
Antibodies (Basel, Switzerland)|September 24, 2019
Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of CancerTimothée Chanier, Patrick Chames
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Phage display and selections on cellsKlervi Even-Desrumeaux, Patrick Chames
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Affinity determination of biotinylated antibodies by flow cytometryKlervi Even-Desrumeaux, Patrick Chames
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Medecine Sciences : M/S|December 29, 2009
[The future of antibody fragments, made of a single immunoglobulin domain]Patrick Chames, Daniel Baty
Mabs|January 16, 2010
Bispecific antibodies for cancer therapy: the light at the end of the tunnel?Patrick Chames, Daniel Baty
Current Opinion in Drug Discovery & Development|April 1, 2009
Bispecific antibodies for cancer therapyPatrick Chames, Daniel Baty
Medecine Sciences : M/S|January 7, 2020
[Bispecific antibodies, novel therapeutic candidates harnessing the immune system]Patrick Chames, Thierry Wurch
Methods in Molecular Biology (Clifton, N.J.)|September 10, 2018
Phage Display and Selections on Purified AntigensMagali Colazet, Patrick Chames
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Phage display and selections on purified antigensJulie Matz, Patrick Chames
Antibodies (Basel, Switzerland)|March 12, 2020
Special Issue: NanobodyPatrick Chames, Ulrich Rothbauer
Antibodies (Basel, Switzerland)|September 24, 2019
Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of CancerTimothée Chanier, Patrick Chames
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Phage display and selections on cellsKlervi Even-Desrumeaux, Patrick Chames
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Affinity determination of biotinylated antibodies by flow cytometryKlervi Even-Desrumeaux, Patrick Chames
Pageof 9